首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Immunochemical quantitation of complement components of Clq and C3 in sera and synovial fluids of patients with bone and joint diseases.
【2h】

Immunochemical quantitation of complement components of Clq and C3 in sera and synovial fluids of patients with bone and joint diseases.

机译:骨和关节疾病患者血清和滑液中Clq和C3补体成分的免疫化学定量分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The amount of the initiating complement component (Clq) in the classical pathway and the first essential component (C3) in the alternative complement pathway were measured with a single radial immunodiffusion (SRID). A high ionic strength was used corresponding to that of 0 . 25 M NaCl and 0 . 01 M EDTA to avoid nonspecific binding of Clq with immune aggregates. Measurements were made on sera and/or synovial fluids from 165 patients with various bone and joint diseases. Values of Clq and C3 in synovial fluids were also expressed as ratios to that of albumin in the same specimens to avoid the influence of differences in volume of synovial fluid in various diseases, and this appeared to provide a reliable index reflecting pathological conditions. Both serum Clq and C3 levels were raised highly in rheumatoid arthritis, gout, and osteomyelitis, but the extent of the elevation of C3 was less conspicuous. Values of Clq and C3 in synovial fluids also markedly increased in rheumatoid arthritis.
机译:用单次径向免疫扩散(SRID)测量经典途径中的起始补体成分(Clq)和替代性补体途径中的第一基本成分(C3)的量。使用对应于0的高离子强度。 25 M NaCl和0。 01 M EDTA以避免Clq与免疫聚集体的非特异性结合。对来自165名患有各种骨和关节疾病的患者的血清和/或滑液进行了测量。滑液中Clq和C3的值也表示为同一标本中白蛋白的比率,以避免各种疾病中滑液体积差异的影响,这似乎提供了反映病理状况的可靠指标。在类风湿性关节炎,痛风和骨髓炎中,血清Clq和C3水平均升高,但C3升高的程度不那么明显。在类风湿关节炎中,滑液中Clq和C3的值也明显增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号